Vaccine Research Market by End-user, Age Group and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 160 SKU: IRTNTR71157

Vaccine Research Market Forecast 2023-2027

The global vaccine research market size is estimated to grow by USD 17.59 billion at a CAGR of 9.88% between 2022 and 2027. 

An important factor driving the growth of the global market is the research for novel adjuvants and vaccine delivery technologies to improve vaccine efficacy and stability. Adjuvants, which are used to improve the immune system response, are chemicals that are injected into vaccines. New adjuvants and dosage methods are under investigation to improve the immune response caused by vaccines. The immune response is strengthened by this highly focused delivery mechanism, which boosts the efficacy of the vaccine. Researchers are trying to improve vaccine formulations, enhance their efficacy and possibly reduce the number of vaccines required for each person. These developments will help meet the global demand for effective vaccinations against many infectious illnesses by enabling the production of more effective and potent vaccines.  

What will be the size of the Vaccine Research Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by End-user, Age Group, and Geography Analysis

End-user analysis

Public

The market share growth by the public segment will be significant during the forecast period. Government organizations fall under the public end-user segment. Various government organizations are involved in the research of vaccines, such as the US National Institute of Allergy and Infectious Diseases (NIAID) and the US National Institutes of Health (NIH). The efforts taken by governments from around the world to develop and put into use a number of COVID-19 vaccines have resulted, in particular from massive and sustained investment which has been made over many decades.

Get a glance at the market contribution of various segments View a PDF Sample

The public segment was valued at USD 11.31 billion in 2017. Governments have largely funded and invested in each and every aspect, starting from the basic science and pre-clinical development to the clinical trials for these vaccines. Based on a wide range of possible sources and the timing of data collection, it is significantly different in terms of estimates of actual government expenditure for the R&D of COVID-19 vaccines.

Private

Private pharmaceutical companies have been at the forefront of discovering, developing, and delivering a range of effective vaccines to help prevent disease around the world for more than 100 years. Various vaccine R&D strategies, e.g. collaboration with governments, academics, and NGOs all over the world, are constantly being implemented by vendors. There has been a rise in private R&D spending as well as the introduction of new vaccines. The outbreak of the COVID-19 pandemic has stimulated the R&D of vaccines to contain the COVID-19 pandemic. In addition to R&D spending by the private sector, governments across the world have provided support to the private sector to develop vaccines to contain the pandemic.

Age Group analysis

Pediatric

The pediatric age group is of high significance in the global market due to the sustained emphasis on the creation and delivery of vaccines for children. The health of children across the world has been greatly improved and as a result of the global vaccination programs for children, different infectious childhood diseases have been eradicated. The market environment for pediatric vaccinations is characterized by rising R&D spending, stringent regulatory standards, and rising demand for vaccines that are both safe and efficacious for children. New vaccines to prevent diseases such as rotavirus and pneumococcal infections that cause high morbidity and mortality in children are also being developed. The emphasis on pediatric vaccinations also underlines the dedication to preserving the health and welfare of children, which, in turn, will drive the growth of the market in focus during the forecast period.

Adult

The pediatric age group is of high significance in the global market due to the sustained emphasis on the creation and delivery of vaccines for children. Thanks to childhood vaccination programs in the world, children's health worldwide has greatly improved, and infectious diseases such as measles have been eliminated. The market environment for pediatric vaccinations is characterized by rising R&D spending, stringent regulatory standards, and rising demand for vaccines that are both safe and efficacious for children. For diseases such as rotavirus or pneumococcal infections with high morbidity and mortality in children, new vaccines are also being developed. The emphasis on pediatric vaccinations also underlines the dedication to preserving the health and welfare of children, which, in turn, will drive the growth of the market in focus during the forecast period. 

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America holds one of the largest shares of the global market, primarily due to the strong prevalence of infectious diseases, such as influenza, hepatitis A, hepatitis B, HIV, measles, malaria, and tuberculosis, and non-infectious diseases, such as cancer.  In developed countries in this region, the number of infectious and uninfectious diseases has been steadily increasing. Although there has been a gradual reduction in the number of infections caused by mumps, measles, and rubella MMR across the United States, they are still not fully eradicated. Therefore, the government in the region, in collaboration with several private players, has worked toward the betterment of R and D to neutralize the impact of such infectious diseases. 

Buy Now Full Report and Discover More

Key Vaccine Research Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market research and growth market report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories - The company offers vaccine research for therapy areas such as Anti incentives, Cardio Diabeto and Neuro Psychiat.

  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • CanSino Biologics Inc. 
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Moderna Inc.
  • Novavax Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Creative Biogene

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Market: Key Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends, and challenges. 

Significant Trends

The adoption of AI to speed up the R&D of vaccines is the primary trend in market drivers.  Artificial intelligence has the potential to lead to new vaccines being discovered and developed. AI helps convert data into valuable knowledge to understand the disease to be treated, design better clinical trials, and speed up the way we design and develop vaccines. To increase the productivity of R&D, AI tools assist vaccine researchers in their discovery of new biological insights.

Moreover, AI is also used for analyzing images in real-time and has helped researchers try to pick out genetic mutations and variations. This way, the virus can be identified with new variants and mutations. In this way, artificial intelligence can be a major tool for developing vaccines. Hence, the adoption of Ai in the R&D of vaccines is expected to be a significant trend driving the growth of the market in focus during the forecast period.

Major Challenges

The high cost of vaccine research, development, and manufacturing is a major challenge in the market.  Vaccine development has a major role to play in the fight against many of the life-threatening diseases. Despite this achievement, there is still a great need for new vaccines. However, global achievements such as the eradication of smallpox have been slow due to the need for huge investments in the development and manufacture of vaccines. In order to develop vaccines that can contribute to the world's preparedness against and prevention of epidemics and pandemics caused by infection, a Consortium for Epidemiological Preparedness Innovations has been created under the name CEPI.

Moreover, the cost of vaccines is expected to be high for humans due to the costs involved in research, development, and manufacturing. The high cost of vaccines harms patient compliance and adherence to vaccine protocols, which limits market growth. Therefore, it has become important to develop vaccines with novel routes of administration coupled with low cost. Thus, the high cost of vaccine research, development, and manufacturing will hurt the growth of the global market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting market growth and trends report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Vaccine Research Market Customer Landscape

Market Analyst Overview

The Global Vaccine Research Market shows promising growth with a Compound Annual Growth Rate (CAGR). A new research study analyzes industry trends, pricing, and patents. Conference and webinar materials involve key stakeholders and buying behavior. Research targets diseases like dengue fever, Zika virus, Chikungunya, and TB, with oversight from WHO and the European Centre for Disease Prevention and Control. Development costs are significant, monitored by regulatory bodies like the US FDA and ICH. Vaccine types include conjugate, recombinant, inactivated & subunit, live attenuated, and toxoid, with companies like Sinovac, Incepta Pharma, and Valneva Se leading the charge.

Segment Overview

The market growth analysis report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-User Outlook (USD Billion, 2017 - 2027)
    • Public
    • Private
  • Age Group Outlook (USD Billion, 2017 - 2027)
    • Pediatric
    • Adult
  • Region Outlook (USD Billion, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Australia
      • Brazil

Vaccine Research Market Scope

Report Coverage

Details

Page number

160

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.88%

Market growth 2023-2027

USD 17.59 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

8.8

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Creative Biogene

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our market growth and trends report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Vaccine Research Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Age Group
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global vaccine research market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global vaccine research market 2017 - 2021 ($ billion)
    • 4.2 End-User Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-User Segment 2017 - 2021 ($ billion)
    • 4.3 Age Group Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Age Group Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Public - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Public - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Public - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Public - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Public - Year-over-year growth 2022-2027 (%)
    • 6.4 Private - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Private - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Private - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Private - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Private - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by End-user
      • Exhibit 42: Market opportunity by End-user ($ billion)
      • Exhibit 43: Data Table on Market opportunity by End-user ($ billion)

    7 Market Segmentation by Age Group

    • 7.1 Market segments
      • Exhibit 44: Chart on Age Group - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Age Group - Market share 2022-2027 (%)
    • 7.2 Comparison by Age Group
      • Exhibit 46: Chart on Comparison by Age Group
      • Exhibit 47: Data Table on Comparison by Age Group
    • 7.3 Pediatric - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Pediatric - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Data Table on Pediatric - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 50: Chart on Pediatric - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Pediatric - Year-over-year growth 2022-2027 (%)
    • 7.4 Adult - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Adult - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Data Table on Adult - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 54: Chart on Adult - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Adult - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Age Group
      • Exhibit 56: Market opportunity by Age Group ($ billion)
      • Exhibit 57: Data Table on Market opportunity by Age Group ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ billion)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 107: Abbott Laboratories - Overview
              • Exhibit 108: Abbott Laboratories - Business segments
              • Exhibit 109: Abbott Laboratories - Key news
              • Exhibit 110: Abbott Laboratories - Key offerings
              • Exhibit 111: Abbott Laboratories - Segment focus
            • 12.4 Astellas Pharma Inc.
              • Exhibit 112: Astellas Pharma Inc. - Overview
              • Exhibit 113: Astellas Pharma Inc. - Product / Service
              • Exhibit 114: Astellas Pharma Inc. - Key news
              • Exhibit 115: Astellas Pharma Inc. - Key offerings
            • 12.5 AstraZeneca Plc
              • Exhibit 116: AstraZeneca Plc - Overview
              • Exhibit 117: AstraZeneca Plc - Product / Service
              • Exhibit 118: AstraZeneca Plc - Key news
              • Exhibit 119: AstraZeneca Plc - Key offerings
            • 12.6 Bavarian Nordic AS
              • Exhibit 120: Bavarian Nordic AS - Overview
              • Exhibit 121: Bavarian Nordic AS - Product / Service
              • Exhibit 122: Bavarian Nordic AS - Key offerings
            • 12.7 Bharat Biotech Ltd.
              • Exhibit 123: Bharat Biotech Ltd. - Overview
              • Exhibit 124: Bharat Biotech Ltd. - Product / Service
              • Exhibit 125: Bharat Biotech Ltd. - Key news
              • Exhibit 126: Bharat Biotech Ltd. - Key offerings
            • 12.8 CanSino Biologics Inc.
              • Exhibit 127: CanSino Biologics Inc. - Overview
              • Exhibit 128: CanSino Biologics Inc. - Product / Service
              • Exhibit 129: CanSino Biologics Inc. - Key offerings
            • 12.9 CSL Ltd.
              • Exhibit 130: CSL Ltd. - Overview
              • Exhibit 131: CSL Ltd. - Business segments
              • Exhibit 132: CSL Ltd. - Key news
              • Exhibit 133: CSL Ltd. - Key offerings
              • Exhibit 134: CSL Ltd. - Segment focus
            • 12.10 Daiichi Sankyo Co. Ltd.
              • Exhibit 135: Daiichi Sankyo Co. Ltd. - Overview
              • Exhibit 136: Daiichi Sankyo Co. Ltd. - Product / Service
              • Exhibit 137: Daiichi Sankyo Co. Ltd. - Key news
              • Exhibit 138: Daiichi Sankyo Co. Ltd. - Key offerings
            • 12.11 Emergent BioSolutions Inc.
              • Exhibit 139: Emergent BioSolutions Inc. - Overview
              • Exhibit 140: Emergent BioSolutions Inc. - Product / Service
              • Exhibit 141: Emergent BioSolutions Inc. - Key news
              • Exhibit 142: Emergent BioSolutions Inc. - Key offerings
            • 12.12 GlaxoSmithKline Plc
              • Exhibit 143: GlaxoSmithKline Plc - Overview
              • Exhibit 144: GlaxoSmithKline Plc - Business segments
              • Exhibit 145: GlaxoSmithKline Plc - Key news
              • Exhibit 146: GlaxoSmithKline Plc - Key offerings
              • Exhibit 147: GlaxoSmithKline Plc - Segment focus
            • 12.13 Johnson and Johnson Services Inc.
              • Exhibit 148: Johnson and Johnson Services Inc. - Overview
              • Exhibit 149: Johnson and Johnson Services Inc. - Business segments
              • Exhibit 150: Johnson and Johnson Services Inc. - Key news
              • Exhibit 151: Johnson and Johnson Services Inc. - Key offerings
              • Exhibit 152: Johnson and Johnson Services Inc. - Segment focus
            • 12.14 Merck and Co. Inc.
              • Exhibit 153: Merck and Co. Inc. - Overview
              • Exhibit 154: Merck and Co. Inc. - Business segments
              • Exhibit 155: Merck and Co. Inc. - Key news
              • Exhibit 156: Merck and Co. Inc. - Key offerings
              • Exhibit 157: Merck and Co. Inc. - Segment focus
            • 12.15 Novavax Inc.
              • Exhibit 158: Novavax Inc. - Overview
              • Exhibit 159: Novavax Inc. - Product / Service
              • Exhibit 160: Novavax Inc. - Key offerings
            • 12.16 Panacea Biotec Ltd.
              • Exhibit 161: Panacea Biotec Ltd. - Overview
              • Exhibit 162: Panacea Biotec Ltd. - Product / Service
              • Exhibit 163: Panacea Biotec Ltd. - Key offerings
            • 12.17 Pfizer Inc.
              • Exhibit 164: Pfizer Inc. - Overview
              • Exhibit 165: Pfizer Inc. - Product / Service
              • Exhibit 166: Pfizer Inc. - Key news
              • Exhibit 167: Pfizer Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations
              • growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
                • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

                  Research Framework

                  Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                  INFORMATION SOURCES

                  Primary sources

                  • Manufacturers and suppliers
                  • Channel partners
                  • Industry experts
                  • Strategic decision makers

                  Secondary sources

                  • Industry journals and periodicals
                  • Government data
                  • Financial reports of key industry players
                  • Historical data
                  • Press releases

                  DATA ANALYSIS

                  Data Synthesis

                  • Collation of data
                  • Estimation of key figures
                  • Analysis of derived insights

                  Data Validation

                  • Triangulation with data models
                  • Reference against proprietary databases
                  • Corroboration with industry experts

                  REPORT WRITING

                  Qualitative

                  • Market drivers
                  • Market challenges
                  • Market trends
                  • Five forces analysis

                  Quantitative

                  • Market size and forecast
                  • Market segmentation
                  • Geographical insights
                  • Competitive landscape

                  PURCHASE FULL REPORT OF

                  vaccine research market

                  QUICK BUY

                  Key Questions Answered

                  • What are the key global market and the regional market share?
                  • What are the revenue-generating key market segments?
                  • What are the key factors driving and challenging this market’s growth?
                  • Who are the key market vendors and their growth strategies?
                  • What are the latest trends influencing the growth of this market?
                  • What are the variables influencing the market growth in the primary regions?
                  • What are the factors influencing the growth of the parent market?

                  Why should you prefer Technavio's market insights report?

                  • Off-the-shelf research reports
                  • Reports can be tailored to meet the customer's needs
                  • Trusted by more than 100 fortune 500 organizations
                  • Information about the market's key drivers, trends, and challenges
                  • Parent market analysis
                  • Every week, 50,000 people visit our subscription platform
                  • Detailed vendors report with competitive landscape
                  • Covid-19 impact and recovery analysis
                  • Data on revenue-generating market segments
                  • Details on the market shares of various regions
                  • Five-force market analysis